Rethinking treatment strategies for idiopathic pulmonary fibrosis: Reevaluation of anti-inflammatory and immunosuppressive therapies.

Bando, Masashi

Bando, Masashi.

Affiliation

Bando M; Division of Pulmonary Medicine, Department of Medicine, Jichi Medical University, 3311-1, Yakushiji, Shimotsuke, Tochigi, 320-0498, Japan. Electronic address: bando034@jichi.ac.jp.

Respir Investig ; 61(1): 58-60, 2023 01.

Article in En | MEDLINE | ID: mdl-36460586

Subject(s)

Idiopathic Pulmonary Fibrosis; Humans; Idiopathic Pulmonary Fibrosis/drug therapy; Anti-Inflammatory Agents/therapeutic use; Immunosuppression Therapy; Pyridones/therapeutic use

Key words

Anti-inflammatory and immunosuppressive therapies; Antifibrotic therapy; Combination therapy; Idiopathic pulmonary fibrosis (IPF); Immunopathogenesis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Idiopathic Pulmonary Fibrosis Limits: Humans Language: En Journal: Respir Investig Year: 2023 Document type: Article Country of publication: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google